Company page

Pulmonx Corporation

Pulmonx Corporation, trading under the ticker LUNG, operates in the American market with a current market cap of approximately $57.9 million. The company focuses on innovative solutions for lung diseases, aiming to improve patient outcomes. Pulmonx is committed to advancing its technology and expanding its presence in the healthcare sector.